Pharmigene is licensed with exclusive worldwide rights to key technologies from Academia Sinica, Taiwan (Risk Assessment for Adverse Drug Reactions) and entered into a collaboration with the Genomics Research Center at Academia Sinica.
Pharmigene received ISO-13485 certification (Verification Unit: SGS).